Evidence map›Paper›PMID 33266302›Full record

ReviewInternational journal of molecular sciences2020

Exposure to Endocrine Disrupting Chemicals and Risk of Breast Cancer.

Louisane Eve, Béatrice Fervers, Muriel Le Romancer, Nelly Etienne-Selloum

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Estrogenic activity in tampon products.Journal of the Endocrine Society · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Spiegelmer Aptamers: Innovative Approach in Breast Cancer.Breast cancer : basic and clinical research · 2026
    Review
  14. Article
  15. PI3 K/AKT/mTOR pathway and its role in breast cancer stem cells.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Louisane EveFaculté de Pharmacie, Université de Strasbourg, F-67000 Strasbourg, France.
Béatrice FerversCentre de Lutte Contre le Cancer Léon-Bérard, F-69000 Lyon, France.
Muriel Le RomancerUniversité Claude Bernard Lyon 1, F-69000 Lyon, France.ORCID 0000-0002-8491-4015
Nelly Etienne-SelloumFaculté de Pharmacie, Université de Strasbourg, F-67000 Strasbourg, France.ORCID 0000-0002-4558-4594
Université Claude Bernard Lyon 1 · FRCentre National de la Recherche Scientifique · FRInserm · FR

Funding

Ligue contre le cancer 2020
6 · The paper itself

Abstract

Breast cancer (BC) is the second most common cancer and the fifth deadliest in the world. Exposure to endocrine disrupting pollutants has been suggested to contribute to the increase in disease incidence. Indeed, a growing number of researchershave investigated the effects of widely used environmental chemicals with endocrine disrupting properties on BC development in experimental (in vitro and animal models) and epidemiological studies. The complex effects of endocrine disrupting chemicals (EDCs) on hormonal pathways, involving carcinogenic effects and an increase in mammary gland susceptibility to carcinogenesis-together with the specific characteristics of the mammary gland evolving over the course of life and the multifactorial etiology of BC-make the evaluation of these compounds a complex issue. Among the many EDCs suspected of increasing the risk of BC, strong evidence has only been provided for few EDCs including diethylstilbestrol, dichlorodiphenyltrichloroethane, dioxins and bisphenol A. However, given the ubiquitous nature and massive use of EDCs, it is essential to continue to assess their long-term health effects, particularly on carcinogenesis, to eradicate the worst of them and to sensitize the population to minimize their use.

Indexed as

Disease SusceptibilityBenzhydryl CompoundsBisphenol A CompoundsBreast NeoplasmsDDTEndocrine DisruptorsEnvironmental ExposureEstradiol CongenersFemaleHumansPhenolsRisk AssessmentRisk FactorsBenzhydryl Compoundsbisphenol ABisphenol A CompoundsDDTEndocrine DisruptorsEstradiol CongenersPhenolsbisphenol Abreast cancerDDTdiethylstilbestroldioxinendocrine disrupting chemicals

Identifiers

PMID33266302
PMCPMC7731339
OpenAlexW3109891523

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.